{'fraction_non_alphanumeric': 0.01954177897574124, 'fraction_numerical': 0.008086253369272238, 'mean_word_length': 5.086065573770492, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Consensus on Choice of Insulin Delivery Devices in Routine Clinical Practice.

Although insulin delivery devices are widely used by the patients, there is a paucity of published guidelines to help professionals manage their patients in insulin therapies. To provide simple and easily implementable guidelines to healthcare physicians on the choice of insulin delivery devices in routine clinical practice, experts in diabetes gathered together and discussed the recommendations at the National insulin Summit 2018.An ideal insulin delivery device should accurately deliver the prescribed dose of insulin and be easy to use. Recommendations are: 1. insulin should be Initiated using insulin device if the patient seems to discontinue insulin therapy. 2. Pen devices offer accurate dosing than syringe and vial and associated with cost savings in the long-term. 3. Switching over from syringes and vial to disposable pen devices improves adherence. 4. FlexPen® offers better accuracy, requires lower dose force and injection force than SoloStar® and KwikPen® * 5. Durable delivery pen like NovoPen® 4 maintain accuracy and low dose force compared to vials and syringes. 6. One pen should be used by only one patient. 7. Regular counselling on the proper use of the pen device is required regularly. This consensus-based recommendation is a useful reference tool for healthcare practitioners to initiate insulin therapy in patients with diabetes using the appropriate insulin pen device.